G6 Materials Enters into Strategic Partnership Agreement to Collaborate on Production with MADE Advanced Materials
The Company's Wholly Owned Subsidiary, Graphene Laboratories Inc., Also Expects to Jointly Develop Intellectual Property with MADE Pursuant to the Terms of the SPA and an IP Ownership Agreement
Ronkonkoma, New York, USA – TheNewswire – December 6, 2022 – G6 Materials Corp. (“G6” or the “Company”) (TSXV: GGG, OTCQB: GPHBF),
a high-tech company with expertise in advanced materials and developing innovative composites for a wide range of industrial uses, announces that its wholly owned subsidiary, Graphene Laboratories Inc. (“GLI”), has entered into a Strategic Partnership Agreement (the “SPA” or the “Agreement”) with Singapore-based MADE Advance Materials PTE LTD. (“MADE”). The Agreement encapsulates the collaboration between GLI and MADE which is focused on production collaboration and the potential joint development of intellectual property (“Joint IP”).
The key terms of the Agreement include but are not limited to:
- MADE and GLI intend to explore the possibility of using the fibre composites with graphene-enhanced resin (the “Collaborative Project”) as necessary to meet specific terms provided by the third-party client (the “Client”);
- The Collaborative Project shall include three stages – the Development Stage, the Prototype Manufacturing Stage and the Production Stage;
- GLI and MADE agree to share the profits of the Collaborative Project and possible future projects;
- GLI and MADE will each cover its own expenses during the development and manufacturing stages of the Collaborative Project and possible future projects;
- GLI is to provide MADE with advanced materials enhanced with graphene; and
- MADE, based on its extensive experience with manufacturing methods including resin transfer moulding, will incorporate this method when working with G6 and GLI.
GLI and MADE have also signed a Joint Intellectual Property Ownership Agreement (the “Joint IP Agreement”) in conjunction with the SPA. All intellectual property that is mutually made, developed, conceived, first reduced to practice, fixed in any tangible means of expression, or created by MADE and GLI during the term of the Agreement will be considered to be Joint IP. The Joint IP Agreement outlines the specific details in relation to any Joint IP created throughout the Agreement as well as the terms that would survive the Agreement once concluded.
GLI and MADE each bring unique value to the arrangement including, but not limited to:
- GLI has expertise in developing formulations of resins enhanced with graphene nanoplatelets and reduced graphene oxide; and
- MADE has expertise in manufacturing components and structures out of glass and carbon fibre composites using advanced manufacturing methods such as wet layout and resin transfer moulding optimized for utilization of the graphene-enhanced resins.
The Company’s Co-CEOs are among the founders of MADE. Currently, Elena Polyakova, Co-CEO of G6, holds a minor ownership position in MADE. However, MADE operates independently of G6 and neither of G6’s Co-CEOs are involved in the management of MADE.
“The Strategic Partnership agreement presents a great opportunity for G6 and its employees, shareholders and stakeholders. The combination of MADE’s capabilities with our graphene-based expertise could very well yield some interesting results for the Collaborative Project and other future projects,” said Dr. Daniel Stolyarov, President & Co-CEO of G6 Materials Corp. “We are excited to work with the MADE team throughout the term of the Strategic Partnership Agreement, as well as under the terms of the Joint IP Agreement, with the goal of developing innovative production solutions and valuable intellectual property. I would like to commend the MADE team on their professionalism and look forward to collaborating with them long into the future. We will provide our shareholders with an update about new commercial opportunities evolved from this very important partnership,” added Dr. Stolyarov.
“We are very excited to sign the SPA with Graphene Laboratories. It is an important milestone in our long-lasting partnership,” said Michel Goedegebuure, CEO of MADE. “The combination of our proprietary manufacturing method with graphene-enhanced formulations developed by our partner is a synergy that will allow us to create novel products and find new customers and offer them this that ground-breaking technology to provide them with a solution they desperately need to achieve their business goals,” added Mr. Goedegebuure.
MADE is a company that aims to introduce a new way of development in the next generation of graphene/fibre-reinforced composite materials. The team at MADE consists of expert scientists, business professionals and engineers who work together to create next-generation materials for high-end applications.1 MADE works within the automotive, marine, and lifestyle industries and offers the following guidance and services to clients:
- Helps clients to find the best way to extract the value from advanced nanomaterials;
- Performs testing and quality assurance;
- Provides turn-key solutions in the field of material design; and
- Determines the shortest route to commercialization for a range of innovative products, based on the client’s needs.
About G6 Materials Corp.
G6 Materials Corp. is a high-tech company with expertise in advanced materials that creates value developing innovative composites for a wide range of industrial uses. Graphene Laboratories Inc., a wholly owned subsidiary of G6, sells a range of graphene-based products and other materials, including but not limited to conductive epoxies, high-performance composites, and R&D materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities. Graphene Laboratories Inc. has entered the global air filtration market with Breathe+, a line of medical-grade HEPA air filtration products enhanced with advanced performance graphene material.
G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprising five granted patents. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Graphene Laboratories Inc., a wholly owned subsidiary of G6 located in Ronkonkoma, New York, has established its premium research laboratory and scalable production facility equipped with advanced analytical and material processing equipment.
The Company’s e-commerce websites are listed below:
- Breathe+: Medical-grade HEPA air filtration enhanced with advanced performance graphene material, for more information, visit breatheplus.tech
- Conductive Epoxies: Adhesive materials distributed under the G6-Epoxy® trade name and can be purchased at g6-epoxy.com
- R&D Materials: Graphene Laboratories Inc. currently offers over 100 graphene and related products available at graphene-supermarket.com
This news release contains forward-looking statements within the meaning of the applicable securities legislation that is based on expectations, estimates and projections as at the date of this news release. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. “Forward-looking information” in this news release includes but is not limited to information about the graphene-enhanced air purifier (including efficacy, potential commercialization and patent pending thereof); information about the potential for the Company’s long-term growth; the business goals and objectives of the Company, and other forward-looking information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.
The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.
Risk factors that could cause actual results to differ materially include, but are not limited to, the risk that actual results in commercial applications of the graphene-enhanced air purifier may differ significantly from the Test Results; the Test Results may not be accepted by applicable regulatory agencies required to approve commercialization of the graphene-enhanced air purifier; the Company may not receive required approvals from regulatory agencies to commercialize the graphene-enhanced air purifier; the Company may not achieve further stages of commercialization of the graphene-enhanced air purifier as anticipated, or at all; the Company patent pending (US20210346831A1) may not be granted; the Company may not achieve anticipated commercial gains or profitability from the sale of Breathe+ Pro Advanced Antimicrobial Graphene Air Filtration System as currently anticipated, or at all; risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; the company may fail to obtain appropriate government approvals or accreditation related to the business’ operations and technological processes; the market conditions and demand for its product as well as the market prices of such products being developed by the company may change over time; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; competition; dilution; and the volatility of our common share price and volume.
The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Daniel Stolyarov, President & Co-CEO
Telephone: (631) 405-5113
Email: [email protected]
Nick Kuzyk, Investor Relations
Email: [email protected]
ON BEHALF OF THE BOARD: Daniel Stolyarov, President & Co-CEO
- “Home”, MADE Advanced Materials, 2022, https://madeadvancedmaterials.com/index.html
SOURCE: G6 Materials Corp.